Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations

Chang Gung Memorial Hospital, Linkou, Taoyuan

National Taiwan University Hospital - YunLin Branch, Huwei

National Cheng Kung University Hospital, Tainan City

Chang Gung Memorial Hospital - Kaohsiung, Kaohsiung City

Cliniques Universitaires Saint-Luc, Brussels

Universitair Ziekenhuis Antwerpen, Edegem

Grand Hopital de Charleroi, Charleroi

NYU Langone Medical Center, New York

Memorial Sloan Kettering Cancer Center, New York

Chulalongkorn University, Bangkok

Taipei Veterans General Hospital, Taipei

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan

ASST Grande Ospedale Metropolitano Niguarda, Milan

CHRU Dijon, Dijon

Centre Georges-Francois Leclerc, Dijon

Frederick Regional Healthcare Systems/James M. Stockman Cancer Institute, Frederick

Hopital Nord Franche-Comte, Montbéliard

Azienda Socio Sanitaria Territoriale di Cremona (ASST), Cremona

Hospital General Universitario Gregorio Maranon, Madrid

Hospital Universitario Ramon y Cajal, Madrid

Hospital Universitario 12 de Octubre, Madrid

Hospital Universitario La Paz, Madrid

Hospital Universitario HM Sanchinarro - CIOCC, Madrid

Levine Cancer Institute - Charlotte, Charlotte

Charleston Oncology, Charleston

Florida Hospital Medical Group, Orlando

UF Health Cancer Center at Orlando Health, Orlando

Istituto Oncologico Veneto - I.R.C.C.S., Padua

Complejo Asistencial Universitario de Salamanca - Hospital Clinico, Salamanca

China Medical University Hospital, Taichung

Hospital Universitario Virgen Macarena, Seville

Ohio State University Comprehensive Cancer Center, Columbus

Klinikum Dortmund gGmbH, Dortmund

University of Cincinnati Medical Center, Cincinnati

Hospital Universitari i Politecnic La Fe de Valencia, Valencia

Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori IRST, Meldola

William Beaumont Hospital, Royal Oak

Barbara Ann Karmanos Cancer Institute - Lawrence and Idell Weisberg Cancer Treatment Center, Detroit

Cancer and Hematology Centers of Western Michigan, Grand Rapids

Hospital Universitario Miguel Servet, Zaragoza

Maharaj Nakorn Chiang Mai Chiang Mai University, Chiang Mai

Hopital Claude Huriez Rue Michel Polonovski (CHRU) Lille, Lille

Northwestern Memorial Hospital, Chicago

University Clinic Heidelberg, Heidelberg

Groupement Hospitalier Edouard Herriot, Lyon

University Medical Center - New Orleans, New Orleans

Universitätsklinikum Tübingen, Tübingen

University of Arkansas for Medical Sciences, Little Rock

Chi Mei Hospital, Liouying, Tainan City

Hopital Cochin, Paris

Parkland Health and Hospital System, Dallas

University of Texas Southwestern Medical Center, Dallas

Hôpital Saint Antoine, Paris

L'Institut Mutualiste Montsouris, Paris

University of Texas MD Anderson Cancer Center, Houston

Baylor College of Medicine, Houston

Klinikum rechts der Isar der Technischen Universität München, München

Banner MD Anderson Cancer Center, Gilbert

University of Arizona, Tucson

USC Norris Cancer Center, Los Angeles

University of California Los Angeles, Los Angeles

Songklanagarind Hospital, Prince of Songkla University, Hat Yai

St. Joseph Heritage Healthcare, Fullerton

Hopital Henri Mondor, Créteil

Peking University People's Hospital, Beijing

Beijing Cancer Hospital, Beijing

Peking University Third Hospital, Beijing

Liaoning Cancer Hospital & Institute, Shenyang

Hunan Cancer Hospital, Changsha

Hubei Cancer Hospital, Hubei

The First Affiliated Hospital, Sun Yat-sen University, Zhongshan

Guangzhou First People's Hospital, Guangzhou

Massachusetts General Hospital, Boston

Chris O'Brien Lifehouse Hospital, Camperdown

Blacktown Hospital, Darlinghurst

Royal Adelaide Hospital, Adelaide

Monash Medical Centre, Bentleigh East

Peninsula & South Eastern Haematology and Oncology Group, Frankston

St John of God Hospital Subiaco, Subiaco

Cross Cancer Institute, Edmonton

St. Josephs Health Centre, Toronto

Pusan National University Hospital, Pusan

Seoul National University Bundang Hospital, Seongnam-si

Samsung Medical Center, Seoul

Seoul National University Hospital, Seoul

Severance Hospital Yonsei University Health System, Seoul

The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul

Ajou University Hospital, Suwon

National Taiwan University Hospital, Taipei

Ramathibodi Hospital Mahidol University, Bangkok

Srinagarind Hospital, Khon Kaen

Naresuan University, Phitsanulok

Ottawa Hospital, Ottawa

Jewish General Hospital, Montreal

Groupe Hospitalier Archet I Et II, Nice

Policlinico Universitario Campus Biomedico Di Roma, Roma

Hospital Beatriz Angelo, Loures

Hospital Garcia de Orta, Almada

Centro Hospitalar E Universitário de Coimbra EPE, Coimbra

Instituto Português de Oncologia Francisco Gentil Centro Regional de Oncologia de Coimbra EPE, Coimbra

Instituto Português de Oncologia de Lisboa Francisco Gentil, E.P.E., Lisbon

Centro Hospitalar Lisboa Norte, E.P.E. - Hospital de Santa Maria, Lisbon

Hospital CUF Descobertas, Lisbon

Centro Hospitalar do Porto - Hospital de Santo António, Porto

Instituto Portugues de Oncologia Do Porto Francisco Gentil Epe - PPDS, Porto

Centro Hospitalar de São João, E.P.E., Porto

Hospital Oncologico, Puerto Rico Medical Center, Rio Piedras

SMG - SNU Boramae Medical Center, Seoul

Hospital Universitario Germans Trias i Pujol, Badalona

Instituto Catalan de Oncologio ICO I'Hospitalet, Barcelona

Hospital Universitario Vall d'Hebrón - PPDS, Barcelona

Nottingham City Hospital, Nottingham

Royal Marsden Hospital, Sutton

The Clatterbridge Cancer Centre NHS Foundation Trust, Bebington

Guys Hospital, London

The Christie NHS Foundation Trust - PPDS, Manchester